Everlaw, the cloud-native investigation and litigation platform, today announced its partnership with Array, a leading litigation support firm. Through the collaboration, Array will incorporate ...
Companies of all sizes outsource at least a portion of their logistics needs. Effective procurement and supply chain teams implement, directly or indirectly, six key elements of logistics outsourcing ...
Recently, I used Costco's Auto Program to save thousands of dollars when buying a car. It was easy to use, and I liked that I didn't have to negotiate or haggle with a dealership. More Costco members ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
A United States District Court judge on Thursday ruled that the Federal Emergency Management Agency (FEMA) was wrong to cancel a program that has funded infrastructure resiliency efforts in ...
NASHVILLE, Tenn. (WSMV) - Tennessee’s new private school voucher program, which provides $7,300 to 20,000 students in its first year, could more than double in size in 2026, a move projected to cost ...
From simple text generation to autonomously powering robotic arms on production lines, AI technology offers enterprises a kaleidoscope of new capabilities. So which aspects of AI advancement have ...
SALT LAKE CITY, UT (Good Things Utah) – Mental health is multifaceted. At Holistic Elements they practice therapeutic modalities like EMDR, IFS, Ego State, Family Systems, Play Therapy, etc. and ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Starting in January, Medicare will test out an artificial intelligence ...
– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio ...
Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...
– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results